Detalles de la búsqueda
1.
A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).
Diabetes Obes Metab
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38715179
2.
Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial.
J Headache Pain
; 25(1): 43, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528476
3.
Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
Int J Urol
; 25(3): 240-245, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29094398
4.
A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial.
Endocr J
; 62(12): 1101-14, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26477324
5.
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.
Neurol Ther
; 13(3): 697-714, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581615
6.
Galcanezumab Effects on Migraine Severity and Symptoms in Japanese Patients with Episodic Migraine: Secondary Analysis of a Phase 2 Randomized Trial.
Neurol Ther
; 12(1): 73-87, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266558
7.
Safety profile of lasmiditan in patients with migraine in an Asian population.
Expert Opin Drug Saf
; 22(1): 91-101, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736027
8.
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial.
Neurol Ther
; 12(6): 2007-2019, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37698836
9.
Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study.
J Pain Res
; 16: 1725-1738, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255987
10.
Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial.
Expert Opin Drug Saf
; 21(12): 1495-1503, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748397
11.
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial.
Lancet Diabetes Endocrinol
; 10(9): 634-644, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35914542
12.
Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial.
Adv Ther
; 39(11): 5274-5288, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36138260
13.
Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial.
Neurol Ther
; 11(4): 1721-1734, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36136232
14.
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study.
Neurol Ther
; 10(1): 265-278, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33835383
15.
Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine.
J Pain Res
; 14: 3555-3564, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34815708
16.
A long-term open-label safety study of galcanezumab in Japanese patients with migraine.
Expert Opin Drug Saf
; 20(6): 721-733, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393835
17.
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study.
J Pain Res
; 13: 3531-3538, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33408512
18.
Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
JAMA Netw Open
; 2(8): e198243, 2019 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31373648
19.
Trajectories of depression symptom improvement and associated predictor analysis: An analysis of duloxetine in double-blind placebo-controlled trials.
J Affect Disord
; 196: 171-80, 2016 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26922146
Resultados
1 -
19
de 19
1
Próxima >
>>